These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36633624)

  • 1. Non-pyrogenic highly pure magnetosomes for efficient hyperthermia treatment of prostate cancer.
    Nguyen TN; Chebbi I; Le Fèvre R; Guyot F; Alphandéry E
    Appl Microbiol Biotechnol; 2023 Feb; 107(4):1159-1176. PubMed ID: 36633624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors.
    Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Gazeau F; Guyot F; Chebbi I
    J Nanobiotechnology; 2019 Dec; 17(1):126. PubMed ID: 31870376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatible coated magnetosome minerals with various organization and cellular interaction properties induce cytotoxicity towards RG-2 and GL-261 glioma cells in the presence of an alternating magnetic field.
    Hamdous Y; Chebbi I; Mandawala C; Le Fèvre R; Guyot F; Seksek O; Alphandéry E
    J Nanobiotechnology; 2017 Oct; 15(1):74. PubMed ID: 29041937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.
    Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I
    Biomaterials; 2017 Oct; 141():210-222. PubMed ID: 28689117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable pharmaceutical composition of cryo-protected non-pyrogenic isotonic chains of magnetosomes for efficient tumor cell destruction at 45 ± 1 °C under alternating magnetic field or ultrasound application.
    Nguyen TN; Chebbi I; Le Fèvre R; Guyot F; Alphandéry E
    Nanoscale; 2024 Oct; 16(40):18984-18997. PubMed ID: 39297787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia.
    Alphandéry E; Guyot F; Chebbi I
    Int J Pharm; 2012 Sep; 434(1-2):444-52. PubMed ID: 22698862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatible and stable magnetosome minerals coated with poly-l-lysine, citric acid, oleic acid, and carboxy-methyl-dextran for application in the magnetic hyperthermia treatment of tumors.
    Mandawala C; Chebbi I; Durand-Dubief M; Le Fèvre R; Hamdous Y; Guyot F; Alphandéry E
    J Mater Chem B; 2017 Sep; 5(36):7644-7660. PubMed ID: 32264239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.
    Le Fèvre R; Durand-Dubief M; Chebbi I; Mandawala C; Lagroix F; Valet JP; Idbaih A; Adam C; Delattre JY; Schmitt C; Maake C; Guyot F; Alphandéry E
    Theranostics; 2017; 7(18):4618-4631. PubMed ID: 29158849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Set-up of a pharmaceutical cell bank of Magnetospirillum gryphiswaldense MSR1 magnetotactic bacteria producing highly pure magnetosomes.
    Chades T; Le Fèvre R; Chebbi I; Blondeau K; Guyot F; Alphandéry E
    Microb Cell Fact; 2024 Feb; 23(1):70. PubMed ID: 38419080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Method for Producing Highly Pure Magnetosomes in Large Quantity for Medical Applications Using
    Berny C; Le Fèvre R; Guyot F; Blondeau K; Guizonne C; Rousseau E; Bayan N; Alphandéry E
    Front Bioeng Biotechnol; 2020; 8():16. PubMed ID: 32133346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of iron-chelating agents on Magnetospirillum magneticum strain AMB-1: stimulated growth and magnetosome production and improved magnetosome heating properties.
    Alphandéry E; Amor M; Guyot F; Chebbi I
    Appl Microbiol Biotechnol; 2012 Nov; 96(3):663-70. PubMed ID: 22707052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuning the Magnetic Response of Magnetospirillum magneticum by Changing the Culture Medium: A Straightforward Approach to Improve Their Hyperthermia Efficiency.
    Gandia D; Marcano L; Gandarias L; Villanueva D; Orue I; Abrudan RM; Valencia S; Rodrigo I; Ángel García J; Muela A; Fdez-Gubieda ML; Alonso J
    ACS Appl Mater Interfaces; 2023 Jan; 15(1):566-577. PubMed ID: 36563339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy.
    Alphandéry E; Faure S; Seksek O; Guyot F; Chebbi I
    ACS Nano; 2011 Aug; 5(8):6279-96. PubMed ID: 21732678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field.
    Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I
    J Control Release; 2017 Sep; 262():259-272. PubMed ID: 28713041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart Magnetotactic Bacteria Enable the Inhibition of Neuroblastoma under an Alternating Magnetic Field.
    Chen C; Wang P; Chen H; Wang X; Halgamuge MN; Chen C; Song T
    ACS Appl Mater Interfaces; 2022 Mar; 14(12):14049-14058. PubMed ID: 35311270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
    Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
    Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Environmental Conditions on High-Yield Magnetosome Production by Magnetospirillum gryphiswaldense MSR-1.
    Hatami-Giklou Jajan L; Hosseini SN; Ghorbani M; Mousavi SF; Ghareyazie B; Abolhassani M
    Iran Biomed J; 2019 May; 23(3):209-19. PubMed ID: 30797225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlocking the Potential of Magnetotactic Bacteria as Magnetic Hyperthermia Agents.
    Gandia D; Gandarias L; Rodrigo I; Robles-García J; Das R; Garaio E; García JÁ; Phan MH; Srikanth H; Orue I; Alonso J; Muela A; Fdez-Gubieda ML
    Small; 2019 Oct; 15(41):e1902626. PubMed ID: 31454160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the Nanostructure and Arrangement of Bacterial Magnetosomes by Small-Angle X-Ray Scattering.
    Rosenfeldt S; Riese CN; Mickoleit F; Schüler D; Schenk AS
    Appl Environ Microbiol; 2019 Dec; 85(24):. PubMed ID: 31604767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of magnetotactic bacteria and magnetosome for cancer treatment: A review emphasizing on practical and mechanistic aspects.
    Alphandéry E
    Drug Discov Today; 2020 Aug; 25(8):1444-1452. PubMed ID: 32561298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.